November 29, 2022

ACS Risk Biomarkers Substantially Increase After mRNA COVID-19 Vaccine

The threat of acquiring acute coronary syndrome (ACS) drastically enhanced in sufferers soon after obtaining mRNA COVID-19 vaccines, in accordance to a report offered at the American Coronary heart Association (AHA) Scientific Sessions 2021, held from November 13 to 15, 2021.

The analyze involved 566 adult males and gals (1:1) aged 28-97 yrs, who were sufferers in a preventive cardiology practice. All patients been given a new PULS Cardiac Take a look at 2-10 months soon after their next COVID-19 vaccine. This take a look at consequence was in contrast with a PULS rating from 3-5 months prevaccination. The PULS Cardiac Take a look at measures many protein biomarkers, such as hepatocyte advancement component [HGF], soluble Fas, and IL-16, and utilizes the outcomes to estimate a 5-year risk rating for new ACS. The PULS score increases with above-ordinary elevation. All participants been given this test each individual 3-6 months for 8 decades.

From prevaccination to postvaccination, the amounts of IL-16 enhanced from 35=/-20 to 82=/-75 above the norm. Soluble Fas confirmed an maximize from 22±15 to 46=/-24 earlier mentioned the norm. HGF rose from 42±12 to 86±31 earlier mentioned the norm. As a consequence, the 5-calendar year ACS PULS risk score amplified from 11% to 25%. By the time the report was published, adjustments had persisted for 2.5 months or extra soon after the second vaccine dose.

Keep on Reading

The study writer concluded that “mRNA [vaccines] considerably boost swelling on the endothelium and T mobile infiltration of cardiac muscle and may account for the observations of improved thrombosis, cardiomyopathy, and other vascular functions subsequent vaccination.”


Gundry SR. mRNA COVID vaccines radically enhance endothelial inflammatory markers and ACS risk as calculated by the PULS cardiac take a look at: a warning. Introduced at: AHA Scientific Sessions 2021 November 13-15, 2021. Poster VMP41.